Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-25

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (Xellia Pharmaceuticals USA LLC)

View source ↗

Summary

The FDA approved an original ANDA for a generic carboprost tromethamine from Xellia Pharmaceuticals USA LLC, marking a new generic product in the market. It is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)